glp-1 options for type 2 diabetes and obesity 2025 The Landscape Of Receptor Agonists In Treatment Ten Top Tips for the

Among the most discussed options are GLP-1 medications, which have helped many individuals achieve meaningful weight loss when combined with lifestyle modifications and medical supervision

According to the Pan American Health Organization (PAHO), over 62 million people in the Americas live with diabetes, while awareness campaigns have expanded screening and treatment access across more than 35 countries, supporting increased adoption of advanced therapies including GLP-1 drugs

DPP-4 inhibitors: impact on glycemic control and cardiovascular risk factors

L.StanglB

The agreement includes provisions requiring certain TransCon technology-based products to be identified and advanced in metabolic diseases to maintain exclusivity in the field [with] additional provisions for cardiovascular diseases. The transaction is expected to close before the end of 2024.